Newswise — Carol Greenlee, MD of Grand Junction Co., has been elected as a director on the board of the American Thyroid Association (ATA). She will serve a four-year term of office (2008"2012).

Kenneth D. Burman, M.D., recently installed ATA President said today "It is my sincere privilege to welcome the newly elected leadership to the ATA Board of Directors." "Dr. Greenlee is a dedicated ATA member, exceptionally qualified to serve as a strong advocate for people with thyroid disease and the clinicians and researchers who work tirelessly on their behalf."

Dr. Carol Greenlee has been in clinical practice in endocrinology, with a special interest in thyroid diseases, since 1986. Most recently she has been in practice in Atlanta, Georgia, as part of the Piedmont Endocrinology Consultants. There she set up and directed the Endocrine Tumor Board, integrated services for thyroid and parathyroid disorder evaluation and treatment, and conducted investigative work on parathyroid imagining, as well as her private practice patient care and teaching as part of University of Georgia School of Pharmacy. She has now relocated to Grand Junction, Colorado, where she will practice at St. Mary's Hospital and will have an academic appointment at the University of Colorado Denver, School of Medicine.

Dr. Greenlee became an ATA member in 1990. She served on the Standards of Care Committee and continued to serve as the committee changed to become the Clinical Affairs Committee (CAC). In 2005 she became Chair of the CAC and now also chairs one of the CAC task force projects on I131 safety recommendations. In addition, she serves on the ATA Hyperthyroid Guidelines Committee. Working with a medical writer in 2001, she rewrote the ATA patient information on hypothyroidism for the brochures and website. She has also been involved with thyroid patient advocacy by serving on the Board of TFA. Dr. Greenlee has been involved in other endocrine activities, including serving on the The Endocrine Society (TES) Annual Meeting Steering Committee and Clinical Affairs Core Committee. She has also served on many task forces for TES and represents TES to the American College of Physicians on the Council of Subspecialty Societies. She has worked with the programs for fellows and "Fellows Days" for both ATA and TES.

In her candidate statement, Dr. Greenlee expressed her commitment to continue the ATA tradition of offering "its members the collegiality and support that make it unique and revered while at the same time increasing its influence beyond members to serve as a resource for other organizations or individuals with regard to matters involving the thyroid."

About the American Thyroid Association (ATA)The American Thyroid Association (ATA) is the lead organization in promoting thyroid health and understanding thyroid biology. The ATA values scientific inquiry, clinical excellence, public service, education, collaboration, and collegiality.

A non-profit medical society founded in 1923, the ATA fulfills its mission through supporting excellence and innovation in research, clinical care, education, and public health. ATA members are physicians and scientists who work to enhance the understanding of thyroid physiology and pathophysiology, improve the diagnosis and treatment of thyroid diseases, and promote the education of physicians, patients, and the public about thyroid disorders.

Thyroid diseases are among the most common disorders of the endocrine system, affecting almost 13 million Americans alone. The ATA has extensive online information for patients on thyroid disease (in English and Spanish) serving the clinician as a resource for patients and the public who look for reliable information on the internet.

To learn more about the ATA, visit: http://www.thyroid.org.

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

79th Annual Meeting of the American Thyroid Association